Ultimo aggiornamento: agosto 17, 2026

New perspective on production of blood cells and immune cells

 

A healthy adult makes about 2 million blood cells every second, E 99 percent of them are oxygen-carrying red blood cells. The other one percent are platelets and the various white blood cells of the immune system. How all the different kinds of mature blood cells are derived from the same “emopoietico” stem cells in the bone marrow has been the subject of intense research, but most studies have focused on the one percent, the immune cells.

 

Their findings are important for understanding disorders such as anemia, diseases of the immune system, and blood cancers such as leukemias and lymphomas.

 

The process by which hematopoietic stem cells give rise to mature blood cells involves multiple populations of progenitor cells that become progressively more committed to a specificfateas they develop into fully mature cells. A major fork in the road is betweenlymphoid progenitors,” which give rise to white blood cells called lymphocytes, E “myeloid progenitors,” which give rise to other kinds of white blood cells, as well as red blood cells and platelets. The majority of cells in the bone marrow are in the myeloid lineage.

A key finding of the new study is that all progenitor cells with myeloid potential produce far more red blood cells than any other cell type. This was surprising because many previous studies in which progenitor cells were grown in cell cultures (“in vitro”) found they had limited capacity to produce red blood cells and platelets. Forsberg said those results now appear to be an artifact of the culture conditions.

It’s been hard to make sense of a lot of those experiments, because we know our bodies need to make a lot of red blood cells and platelets,” ha detto. “Our results show that these progenitor cells retain a lot of red blood cell potential. Infatti, we propose that red blood cell production is the default pathway.

 

By quantifying the numbers of mature blood cells produced from transplanted progenitors, the researchers were able to show that red blood cells were by far the most abundant cell type produced by every type of progenitor cell, with the exception of lymphoid progenitors. Their findings led to the development of a model of hematopoietic differentiation that focuses on red blood cells as the default pathway for all myeloid progenitors.

 

Revisione scientifica di casi

Revisione scientifica del caso

Ti piacerebbe capire se i programmi clinici sono attuali, recenti sviluppi della ricerca, o potrebbero esserlo gli approcci emergenti rilevante per la tua situazione individuale?

Condividi la tua domanda con il nostro team di ricerca scientifica e ricevi informazioni focalizzate sulle aree di ricerca attuale che potrebbero essere pertinente al tuo caso.

  • Revisione delle informazioni fornite
  • Informazioni rilevanti sulla ricerca e sul programma clinico
  • Una risposta chiara focalizzata sulla tua situazione
Cosa succede dopo? Invia la tua domanda, ricevere una revisione scientifica mirata, e ottieni una risposta chiara sulla ricerca e sui programmi clinici rilevanti per la tua situazione.
La tua revisione scientifica sarà preparata da Dott. Helen Melnik, Dottorato di ricerca , chi ha più di 25 anni di esperienza nella ricerca sulle cellule staminali e nei programmi clinici internazionali.

Nessun obbligo. La tua domanda verrà esaminata in modo confidenziale.

Solo informazioni didattiche e di ricerca. Questo servizio no costituiscono un parere medico, diagnosi, prescrizione, o uno personalizzato raccomandazione terapeutica.


NBScienza

organizzazione di ricerca a contratto

Whatsapp